Legal Opinion
Moore v. Lederle Laboratories
Michigan Supreme Court
Decided August 2, 1974No. 9 March Term 1974, Docket No. 54,765PublishedCited by 13 opinions
1Opinion of the CourtT. G. Kavanagh, J.
Plaintiff, Daniel Moore, was born on October 1, 1959, with cystic fibrosis.
From shortly after birth until late 1964 he was treated with tetracycline manufactured by the defendant, Lederle Laboratories. The drug was administered in order to help prevent infections especially those associated with respiratory illnesses.
Due to a side effect of the drug, Daniel Moore’s teeth became permanently stained blue-black. Plaintiffs filed suit against defendant on July 7, 1967 alleging that its product damaged Daniel’s teeth and that defendant failed to discover the negative side effects and warn the…
2Cases cited8 opinions
- Miskiewicz v. SmolenskiMichigan Supreme Court · 1929
- Rouse v. GrossMichigan Supreme Court · 1959
- Bryant v. BiggsMichigan Supreme Court · 1951
- Sima v. WrightMichigan Supreme Court · 1934
- People v. LoomisMichigan Supreme Court · 1895
3 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- Siirila v. BarriosMichigan Supreme Court · 1976
- Bonelli v. Volkswagen of America, IncMichigan Court of Appeals · 1988
- Swanek v. Hutzel HospitalMichigan Court of Appeals · 1982
- Bivens v. Detroit Osteopathic HospitalMichigan Court of Appeals · 1977
- Nicholes v. LorenzMichigan Supreme Court · 1976
8 more not listed; retrieve them via the Exa API.